Concepedia

Frederic Heerinckx

FH

Statistics

Publications

6

Citations

235

H-Index

6

Active since

2016

Affiliations

Retrotope (United States)(Current)

Frederic Heerinckx is an author at Retrotope (United States) specializing in pharmacology, lipid peroxidation markers, and clinical pharmacology.

Publications per year

2016–2021

6

Publications

6

Randomized, clinical trial of RT001: Early signals of efficacy in Friedreich's ataxia

Theresa A. Zesiewicz, Frederic Heerinckx, Robert De Jager et al. · Movement Disorders · 2018 · 85 citations

Medicine, Clinical Pharmacokinetics, Pharmacology +13

Wearable body and wireless inertial sensors for machine learning classification of gait for people with Friedreich's ataxia

Robert LeMoyne, Frederic Heerinckx, Tanya Aranca et al. · 2016 · 71 citations

Education, Neurology, Machine Learning +16

Treatment of infantile neuroaxonal dystrophy with RT001: A di‐deuterated ethyl ester of linoleic acid: Report of two cases

Darius J. Adams, Mark Midei, Jahannaz Dastgir et al. · JIMD Reports · 2020 · 28 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +10

Plasma and Red Blood Cell Membrane Accretion and Pharmacokinetics of RT001 (bis-Allylic 11,11-D2-Linoleic Acid Ethyl Ester) during Long Term Dosing in Patients

J. Thomas Brenna, Genevieve James, Mark Midei et al. · Journal of Pharmaceutical Sciences · 2020 · 21 citations

Pharmacy, Pharmacokinetics, Pharmacology +8

The infantile neuroaxonal dystrophy rating scale (INAD-RS)

Paldeep S. Atwal, Mark Midei, Darius J. Adams et al. · Orphanet Journal of Rare Diseases · 2020 · 16 citations · Full text

Medicine, Neurology, Pediatrics +17

1–5 of 6